Histone Modifications in Therapy

<p>1. Histone modifications in diseases</p> <p>Section I Targeting histone modifications for cancer treatment<br>2. HDAC inhibitors in cancer therapy<br>3. HAT inhibitors in cancer therapy<br>4. Targeting DOT1L for mixed-lineage rearranged leukemia<br>5. BET mechanisms in cancer<br>6. Histone demethylase inhibitors and their potential in cancer treatment<br>7. Targeting chromatin remodelers in urological tumors</p> <p>Section II Targeting histone modifications for infectious disease<br>8. The therapeutic potential of epigenetic manipulation during infectious diseases<br>9. Targeting histone deacetylases for bacterial infections<br>10. Targeting histone epigenetics to control viral infections</p> <p>Section III Targeting histone modifications for treating other pathologies<br>11. Targeting histone modifications in psychotic disorders<br>12. Epigenetic treatment of neurodegenerative diseases<br>13. Histone modification as a potential preventative and therapeutic approach for cardiovascular disease<br>14. The potentiality of histone deacetylase inhibitors for diabetes and obesity<br>15. Targeting histone modifications in cancer immunotherapy<br>16. Epigenetic drug development for autoimmune and inflammatory diseases<br>17. Future perspectives for targeting histone modifications in therapy</p>